July 22- Health insurer Centene Corp reported a 24 percent jump in quarterly profit, beating market estimates for the sixth straight quarter, as member signups surged 23 percent. The company's shares rose as much as 8.5 percent to hit a life high of $81.98 on the New York Stock Exchange on Tuesday. Centene said it had 3.2 million members as of June 30.» Read More
A Berkshire Hathaway subsidiary's move to stop insuring bank deposits above federal limits apparently reflects Warren Buffett's worries about future bank failures. Several reports say that Kansas Bankers Surety in Topeka is getting out of the business of backing deposits above the $100,000 limit guaranteed by the Federal Deposit Insurance Corp. for many bank accounts. And the Wall Street Journal says this morning that the decision came from Buffett himself. "Two people briefed on the matter said the order was made Monday by Mr. Buffett."
As job losses in the United States have leaped, a second economic stimulus package has become “warranted and necessary,” House Majority Leader Rep. Steny Hoyer (D-Md.) told CNBC Monday.
John Sullivan, the Director of Research at Lerrink Swann, which specializes in healthcare stocks, says there is a potential trading opportunity in the sector related to F & F.
Settlement negotiations between lawyers representing former AIG chief Hank Greenberg and the New York Attorney General are at a stalemate.
Cheaper medications await if you know where to look.
Analysts say Gustav’s punishing blow to the Louisiana coastline Monday will cost nowhere near as much as Katrina three years ago, the New York Times reports..
If you're not covered, this is what you need to do now.
After the closing bell Monday, Eli Lilly and Amylin Pharmaceuticals announced that they're going to hold a conference call for analysts and investors about their diabetes drug Byetta. Why?
As we head into my last free summer weekend before USC's football season kicks off, I wanted to clean out the Pharma's Market mailbox. (Actually I was looking for an apropos-of-nothing excuse to mention the Trojans.)
The market cap of Dow component Johnson & Johnson is a whopping $200 billion. Abbott Labs is valued at less than half that. But think of ABT as kind of a mini-me JNJ because like Johnson & Johnson, ABT has cobbled together a similar three-siloed business of drugs, devices and consumer products.
Flying isn't the only rip-off. Your whole vacation is littered with hidden fees and surcharges, but you don't have to pay them all.
Before I get to my favorite biotech saga, there are noteworthy, if not newsworthy, press releases out this morning from two takeout targets. Genentech put out a statement from the special independent board committee that's been appointed to handle the Roche buyout offer.
European financial groups ING and Zurich Financial Services reported quarterly profits that met or exceeded expectations on Wednesday, helped by strong insurance businesses and limited investment writedowns.
American International Group, the world's largest insurer, may have to raise more capital to bolster its balance sheet if its credit ratings are cut again, Goldman Sachs analyst Tom Cholnoky said in a note to clients.
AIG reports weak earnings and further write-downs, while GE says the Beijing Olympics will help boost the company's brand image. Following are today's top videos:
Stocks ended near session lows as oil ended above $120 a barrel and two Dow components missed the Street's targets.
Stocks pared some losses Thursday afternoon as oil prices flattened out. Putting pressure on stocks today was a quartet of dismal news: a rise in jobless claims, oil's resurgence, Wal-Mart's sales miss and AIG's wider-than-expected loss.
AXA Europe's second-biggest insurer, reported lower first-half net profit on Thursday although the earnings came in above the average market forecast and AXA said it needed no capital increase.
Stocks opened lower, clipped by a quartet of dismal news: a rise in jobless claims, oil's resurgence, Wal-Mart's sales miss and AIG's wider-than-expected loss. But a better-than-expected report on home sales helped shave a few points off the decline.
Stock futures fell further after a report showed jobless claims unexpectedly rose last week. Futures had already been pointing lower as oil rose nearly $3 a barrel, Wal-Mart missed sales estimates and Dow component AIG posted a wider-than-expected loss.
Get the best of CNBC in your inbox